pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
minocycline hydrochloride SR
Arestin (minocycline hydrochloride)
Periodontitis
OraPharma Inc
0 catalysts
Phase 3
minoxidil ER
minoxidil
Androgenic Alopecia
Sulfonylurea receptor 2, Kir6.2
$MANEVeradermics, Inc
0 catalysts
Phase 2
mipletamig
mipletamig [INN]
Refractory Acute Myeloid Leukemia
$APVOAptevo Therapeutics Inc.
← prev
page 232 of 271
next →
131
Pain89
Neurology1
0 catalysts
Marketed
mirabegron SR
Mirabegron (mirabegron)
Neurogenic Bladder Dysfunction
Qilu Pharmaceutical Co Ltd
0 catalysts
Phase 2
miransertib mesylate
Proteus Syndrome
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
mirdametinib
Gomekli (mirdametinib)
Non-Small Cell Lung Cancer
Dual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
SpringWorks Therapeutics Inc
0 catalysts
Marketed
mirdametinib ODT
Gomekli (mirdametinib)
Neurofibromatoses Type I (Von Recklinghausen's Disease)
SpringWorks Therapeutics Inc
0 catalysts
Phase 3
mirodenafil dihydrochloride
Alzheimer's Disease
AriBio Co Ltd
0 catalysts
Marketed
mirvetuximab soravtansine
Elahere (mirvetuximab soravtansine-gynx)
Epithelial Ovarian Cancer
ImmunoGen Inc
0 catalysts
Phase 2
misoprostol
Misoprostol Greenstone (misoprostol)
Labor And Delivery
Prostaglandin E2 receptor EP3 subtype
AFYX Therapeutics A/S
0 catalysts
Marketed
mitapivat sulfate
Pyrukynd (mitapivat sulfate)
Acquired (Autoimmune) Hemolytic Anemia
Pyruvate kinase PKLR
$AGIOAGIOS PHARMACEUTICALS, INC.
0 catalysts
Phase 2
mitazalimab
mitazalimab [INN]
Pancreatic Ductal Adenocarcinoma
Alligator Bioscience AB
0 catalysts
Phase 2
mitolactol
mitolactol [INN]
Glioblastoma Multiforme (GBM)
Eleison Pharmaceuticals Inc
0 catalysts
Marketed
mitomycin
Mitosol (mitomycin)
Glaucoma
Mobius Therapeutics LLC
0 catalysts
Marketed
mitomycin SR
Zusduri (mitomycin)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$URGNUroGen Pharma Ltd.
0 catalysts
Marketed
mitotane
Lysodren (mitotane)
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Esteve Pharmaceuticals SA
0 catalysts
Marketed
mitoxantrone hydrochloride
Mitoxantrone Hydrochloride (mitoxantrone hydrochloride)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
0 catalysts
Phase 3
mivocabtagene autoleucel
mivocabtagene autoleucel [INN]
Myasthenia Gravis
$KYTXKyverna Therapeutics, Inc.
0 catalysts
Phase 2
mocaciclib
mocaciclib [INN]
Endometrial Cancer
Qurient Co Ltd
0 catalysts
Phase 3
mocravimod hydrochloride
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Priothera Ltd
0 catalysts
Marketed
modafinil
Modafinil (modafinil)
Obstructive Sleep Apnea
Appco Pharma LLC
0 catalysts
Marketed
moexipril hydrochloride
Moexipril Hydrochloride (moexipril hydrochloride)
Hypertension
Chartwell Pharmaceuticals LLC
0 catalysts
pre_registration
molgramostim
Molbreevi (molgramostim)
Lung Disease
$SVRASavara Inc
0 catalysts
Marketed
molindone hydrochloride
Molindone Hydrochloride (molindone hydrochloride)
Schizophrenia
Epic Pharma LLC
0 catalysts
Phase 2
mometasone furoate
Sinuva (mometasone furoate)
Eosinophilic Esophagitis
Glucocorticoid receptor
EsoCap AG
0 catalysts
Phase 3
monepantel
monepantel [INN]
Amyotrophic Lateral Sclerosis
Neurizon Therapeutics Ltd
0 catalysts
Phase 2
monlunabant
monlunabant [INN]
Diabetic Nephropathy
Inversago Pharma Inc
0 catalysts
Marketed
monomethyl fumarate DR
Bafiertam (monomethyl fumarate)
Relapsing Remitting Multiple Sclerosis (RRMS)
Cycle Pharmaceuticals Ltd
0 catalysts
Marketed
montelukast sodium
Montelukast Sodium (montelukast sodium)
Chronic Asthma
Senores Pharmaceuticals Inc
0 catalysts
Marketed
morphine sulfate ER
Morphine Sulfate (morphine sulfate)
Pain
Mallinckrodt LLC
0 catalysts